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Abstract
Background: Few studies have addressed risk factors for acute kidney injury (AKI) in geriatric patients. We
investigated whether thrombocytopenia was a risk factor for AKI in geriatric patients with medical illnesses.
Methods: A prospective cohort study was conducted, by recruiting elderly (≥65 years) patients who visited the
emergency department (ED) for medical illnesses during 2014. They all received hemogram for platelet count
determination, and were stratified according to the presence of thrombocytopenia (platelets, <150 K/μL) during
their initial ED evaluation. They were prospectively followed up during their ED stay. We analyzed the relationship
between the diagnosis of thrombocytopenia and subsequent AKI after ED stay, using Cox proportional hazard
modeling, with platelet count as a continuous variable or thrombocytopenia as a categorical variable.
Results: Of 136 elderly patients (mean age of 80.7 ± 8.2 years, 40% with chronic kidney disease, and 39% with
diabetes) enrolled, 22.8% presented with thrombocytopenia, without differences in baseline renal function. After a
mean ED stay of 4.4 ± 2.1 days, 41.9% developed AKI (52.6% Kidney Disease Improving Global Outcomes [KDIGO]
grade 1, 24.6% grade 2, and 22.8% grade 3). Patients with higher AKI severity had stepwise lower platelet counts
compared to those without AKI. The Cox proportional hazard model revealed that lower platelet count as a
continuous variable (hazard ratio [HR] 0.984, 95% confidence interval [CI] 0.975–0.994) and as a categorical variable
(presence of thrombocytopenia) (HR 1.86, 95% CI 1.06–3.27) increased the risk of AKI. The sensitivity analyses
accounting for nephrotoxic medications use, including non-steroidal anti-inflammatory drugs, vancomycin, and
contrast, yielded similar results.
Discussion: Thrombocytopenia is common among ED-visiting elderly, and the potential relationship between
platelet counts and the risk of AKI suggests the utility of checking hemogram for those at-risk ofdeveloping adverse
renal events.
Conclusion: Thrombocytopenia on initial presentation might indicate an increased risk of AKI among elderly
patients with medical illnesses.
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Background
Acute kidney injury (AKI), defined as a rapid decline in
renal function, constitutes a silent epidemic and preferen-
tially affects patients of advanced age. The incidence of
AKI increase progressively with age, and the prevalence
during hospitalization ranges from 10–11% among those
aged 66–69 years to 30–35% among those aged >85 years,
indicating a significant higher risk in the elderly than that
among the general population [1]. The susceptibility of
the elderly to acute renal insults might stem from physio-
logic and pathologic renal degeneration, as well as the
impaired recovery ability of their kidneys [2]. Hospital-ac-
quired AKI in elderly patients increases the risk of mortal-
ity by 3 to 6 fold compared to those without AKI, with
mortality rates as high as 30 to 80% [3, 4]. In addition to
mortality, AKI episodes in the elderly also increase the
probability of a prolonged hospital stay, in-hospital com-
plications, worsening functional status, and the chance of
subsequent institutionalization [5, 6].
Due to the perceived importance of AKI, the risk
factors that can precipitate such episodes have been
widely investigated, but comparatively few studies have
evaluated the risk factors for AKI in the elderly. In the
Cardiovascular Health Study (CHS), researchers deter-
mined that patient demographics and comorbidities,
such as advanced age, the presence of diabetes mellitus
(DM) and chronic kidney disease (CKD), and pre-exist-
ing or subclinical vascular diseases might be associated
with a higher risk of incident AKI among the
community-dwelling elderly [7]. Other researchers have
demonstrated that use of certain medications, such as
antibiotics (vancomycin, aminoglycosides) and non-
steroidal anti-inflammatory drugs, was associated with
increased AKI events among elderly patients with critical
illnesses [8]. However, using laboratory parameters to
gauge the risk of subsequent AKI has not been studied
widely in the geriatric population. Brown et al. reported
that an elevated serum fibroblast growth factor 23 level
predicted a higher risk of AKI in the elderly [9]. Results
from CHS sub-analysis also indicated that blood-based
inflammatory markers, including a higher baseline C-re-
active protein, fibrinogen, and leukocyte counts were in-
dependently associated with an increased frequency of
AKI episodes in the elderly [7].
Thrombocytopenia, a common finding among hospi-
talized patients, can result from infection, bone marrow
suppression, consumptive processes, or treatment-
induced complications including medications, surgery,
or extracorporeal circuitry [10]. The development of
hospital-acquired thrombocytopenia is potentially
associated with a higher risk of adverse outcomes [11].
In addition, several studies have reported that
thrombocytopenia after invasive procedures can be an
important risk factor for the subsequent development of
AKI in post-operative patients [12, 13]. However, none
of these studies evaluated whether the relationship
between thrombocytopenia and the incident AKI exists
among elderly patients, a population with a higher
tendency to develop thrombocytopenia [14]. Using a
prospectively recruited cohort of geriatric patients, we
aimed to investigate whether elderly patients with a find-
ing of thrombocytopenia on the first day of emergency
department (ED) visit had a higher risk of subsequent
AKI after their ED stay.
Methods
Study participant characterization
Elderly (defined as age ≥ 65 years) patients visiting the
NTUH ED for the evaluation of medical illnesses were en-
rolled between Jan and May during 2014, based on a con-
venience sample of patients admitted to the general
medical wards of NTUH. During the initial evaluation in
the ED, clinical features including the patients’ demo-
graphic profiles (age and sex) and past comorbidities were
clarified by interview with patients themselves or their
caregivers if they had altered consciousness, according to
the routine evaluation process in ED. CKD was diagnosed
if the patients had an estimated glomerular filtration rate
(eGFR) < 60 ml/min/1.73 m2, calculated using their pre-
ED visit baseline serum creatinine (Scr) based on Chronic
Kidney Disease Epidemiology Collaboration (CKD-EPI)
formula [15]. Vital signs including systolic blood pressure
(SBP), diastolic blood pressure (DBP), heart rate, respira-
tory rate, and body temperature were measured as a part
of the routine clinical evaluation. All of the participants
underwent blood tests for a complete blood count and
serum biochemistry analysis immediately after evaluation
in the ED, dictated by their caring staff. The ED physicians
provided a preliminary diagnosis for each participant after
analyzing their clinical history, comorbidities, and labora-
tory data. The preliminary diagnoses were divided into
different categories including cardiovascular or cerebro-
vascular events, pulmonary diseases, gastrointestinal and
hepatic diseases, renal-urological diseases, infection of
unknown origin, and others, according to criteria used in
previous studies [16–18]. We collected clinical data,
comorbidities, the initial vital signs, and laboratory data
during the first day in the ED visit for all participants, and
classified the patients according to the presence of initial
thrombocytopenia (defined as platelet count < 150 ×
103/μL) or not immediately after their ED visit. The
elderly participants were prospectively followed up
since the first day of ED visit after blood tests until
the day of their ward admission.
Acute kidney injury as the clinical outcome
The outcome of interest in this study was the develop-
ment of AKI on the day the patients were admitted to
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the general medical wards [5]. None of the participants
were diagnosed with AKI during their initial evaluation
in the ED, through a careful history taking to exclude
the absence of recent changes in urine output levels or
acutely worsening edema prior to ED visit during inter-
view. It has been reported that the presence of periph-
eral edema is strongly associated with higher AKI
incidence [19], and a change in urine output is an estab-
lished criterion of Kidney Disease Improving Global
Outcomes (KDIGO) classification for AKI [20]. Whether
checking serum creatinine was necessary after interview
was left to the attending physicians’ discretion. All of the
participants underwent a test of their Scr after ED stay
when they were admitted to the general medical wards.
The diagnosis of AKI was based upon the comparison
between the patients’ admission and baseline Scr data,
using the (KDIGO) criteria [20], which defines AKI as a
rise in Scr rise of least 0.3 mg/dLwithin 48 h or a 50%
increase from their baseline levels. Stage 1, 2, and 3 AKI
were classified according to a Scr increase of 50 to
100%, 100 to 200%, and ≥ 200% or an increase of Scr to ≥
4 mg/dL, or the initiation of renal replacement therapy,
respectively [21]. The baseline Scr levels were obtained
from pre-admission medical records obtained within
months before their ED visits.
Statistical analysis
We first tested whether the continuous variables de-
scribed in this study conformed to normal distribution,
using a Kolmogorov-Smirnov test. If variables were nor-
mally distributed, they were expressed in the format of
the means ± standard deviations, and comparisons were
made between groups using an independent t-test; if the
variables did not conform to normal distribution, they
were expressed as medians with 25% and 75% values in
parenthesis, and comparisons were made using a Mann-
Whitney U test. Categorical variables were treated in the
format of event numbers with percentages in paren-
theses, and comparisons between groups were made
using the chi-square test. After dividing the cohort ac-
cording to whether they had thrombocytopenia in the
ED or not, we compared the clinical features, comorbidi-
ties, vital signs, and laboratory data between the 2
groups. Platelet counts were analyzed according to the
different AKI grades, and the correlation between plate-
let counts and AKI severity was assessed using the Pear-
son correlation coefficient. We determined the
cumulative hazard of developing AKI over the period of
the ED stay, using stepwise Cox proportional hazard re-
gression analyses with backward variable selection, with
the development of AKI as the dependent variable.
Cumulative hazard curves over the study period were
also constructed to ascertain this relationship. The as-
sumption of proportionality for platelet counts in the
Cox model was checked by calculating the correlation
between Schoenfeld residuals and the follow-up dur-
ation. We used SPSS 18.0 software (SPSS Inc., Chicago,
IL, USA) in this study to perform the statistical analysis.
Two-sided p-values less than 0.05 were considered
statistically significant.
Results
During the study period, a total of 1673 patients (with-
out age selection) were admitted to all medical wards
(including general and specialty-based ones), and
another 107 patients died before admission. We enrolled
136 elderly patients who were admitted to the general
medical wards, with a mean age was 80.7 ± 8.2 years, half
were male, and they had a Charlson comorbidity index
(CCI) of 7 (6–9). More than 50% of the participants had
hypertension, 40% had CKD, 39% had DM, and 26% had
a diagnosis of a malignancy. Pulmonary disorders were
the common preliminary diagnoses (46%) made by the
ED physicians. The participants stayed in ED for an
average of 4.5 (3–6) days; at the end of follow up, 57
(42%) elderly patients were diagnosed with AKI after ED
stay, with a median Scr of 1.1 (0.7–1.9) mg/dL immedi-
ately on ward admission.
Among the study participants, 22.8% had
thrombocytopenia on the first day of their ED visit.
Platelet counts were found to be normally distributed,
with a Kolmogorov-Smirnov test p value of 0.2. The eld-
erly patients with initial thrombocytopenia had a mean
platelet value of 102 ± 51 × 103/μL, compared to those
without (262 ± 82 × 103/μL) (Table 1). No significant dif-
ferences were observed between the elderly patients with
and without initial thrombocytopenia in terms of their
demographic features, most of their comorbidities, CCI,
the ED physicians’ preliminary diagnoses, and their ini-
tial vital signs in ED. We found that the elderly patients
who presented with thrombocytopenia were significantly
less likely to have hypertension and had significantly
lower leukocyte counts (Table 1). Scr on admission and
the ED length of stay did not differ between the groups
with and without thrombocytopenia. In addition, the
amount of fluid administration and the percentage of
patients receiving nephrotoxic medications (non-ster-
oidal anti-inflammatory agents, vancomycin, and others)
did not differ between patients with and without
thrombocytopenia.
Of 57 (41.9%) elderly patients who developed AKI
after their ED stay; 52.6% were classified as grade 1,
24.6% as grade 2, and 22.8% as grade 3. We analyzed the
relationship between the initial ED platelet counts and
subsequent AKI after ED stay. The elderly patients who
presented with thrombocytopenia had a significantly
higher incidence of AKI than the non-thrombocytopenic
patients (61% vs. 36%). The elderly patients who were
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diagnosed with AKI on admission also had signifi-
cantly lower initial platelet counts than those without
AKI (200 ± 100 vs. 243 ± 100 × 103/μL), and a higher
proportion of initial thrombocytopenia (33% vs. 15%).
The patients with higher AKI severity also had step-
wise lower platelet counts compared to the patients
without AKI (non-AKI vs. KDIGO grade 1 vs. 2 vs. 3,
243 ± 101 vs. 200 ± 109 vs. 215 ± 106 vs. 187 ± 82 ×
103/μL). A significant correlation was also observed
between the initial platelet counts and the KDIGO
grades (r = -0.19, p = 0.03).
There were no significant differences between the eld-
erly patients who were diagnosed with AKI after ED stay
and those who were not, in terms of their demographic
profile and most of their comorbidities (Table 2). Elderly
patients who were diagnosed with AKI on admission
had a significantly higher proportion of DM, CKD, and
higher CCI than those without AKI. The elderly patients
Table 1 Elderly patients visiting emergency department for medical illnesses during the study period
Characteristics Total With thrombocytopenia Without thrombocytopenia p value
Demographic features
Age (years) 80.7 ± 8.2 78.5 ± 9.1 81.3 ± 7.8 0.1
Gender (male %) 68 (50) 16 (52) 52 (50) 0.84
Comorbidities
Diabetes mellitus (%) 53 (39) 14 (45) 39 (37) 0.43
Hypertension (%) 78 (57) 11 (35) 67 (64) <0.01
Heart failure (%) 23 (17) 4 (13) 19 (18) 0.5
Coronary artery disease (%) 11 (8) 2 (6) 9 (9) 0.71
Peripheral artery occlusive disease (%) 9 (7) 3 (10) 6 (6) 0.44
Chronic obstructive pulmonary disease (%) 15 (11) 2 (6) 13 (12) 0.36
Chronic kidney disease (%) 54 (40) 14 (45) 40 (38) 0.48
Previous or active malignancy (%) 35 (26) 8 (26) 27 (26) 0.99
Peptic ulcer disease (%) 12 (9) 2 (6) 10 (10) 0.6
Charlson comorbidity index 7 (6–9) 7 (5–9) 8 (6–9) 0.1
Initial impression (%) 0.23
Cardio- or cerebro-vascular events 11 (8) 3 (10) 8 (8)
Pulmonary diseases 63 (46) 10 (32) 53 (50)
Gastrointestinal and hepatic diseases 21 (15) 9 (29) 12 (11)
Renal diseases 14 (10) 3 (10) 11 (10)
Infection of unknown origin 11 (8) 3 (10) 8 (8)
Miscellaneous 16 (12) 3 (10) 13 (12)
First vital signs obtained on ED evaluation
Systolic blood pressure (mmHg) 131 (110.3–153) 133 (101–146) 130 (112–154) 0.89
Diastolic blood pressure (mmHg) 73 (62–84) 71 (60–82) 73 (62–84) 0.73
Heart rate (/min) 96.7 ± 20.8 96.8 ± 27.1 96.7 ± 18.7 0.98
Body temperature (°C) 37.2 ± 1.2 37.2 ± 1.2 37.3 ± 1.1 0.77
Respiratory rate (/min) 20 (18–22) 18 (18–22) 20 (18–22) 0.88
First laboratory data on ED
Leukocyte counts (K/μL) 11.4 (7.9–15.6) 8.2 (4.9–12.3) 12 (8.4–16.5) < 0.01
Hemoglobin (g/dL) 11.4 (9.6–12.8) 11.3 (8.8–12.4) 11.6 (9.6–13.1) 0.47
Platelet counts (K/μL) 225 ± 102 102 ± 51 262 ± 82 < 0.01
Baseline eGFR (ml/min/1.73 m2) 70.3 (42.7–88) 68.9 (39.3–84.4) 70.3 (42.7–89.8) 0.46
Serum creatinine on ward admission (mg/dL) 1.1 (0.7–1.9) 1.5 (0.9–2.1) 1 (0.7–1.7) 0.1
ED length of stay (days) 4.5 (3–6) 4 (3–6) 5 (3–6) 0.64
Data are expressed as mean ± standard deviation or median with 25% and 75% quartiles for continuous variables, and number (percentage) for categorical variables
Abbreviation: ED emergency department, eGFR estimated glomerular filtration rate
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with AKI after ED stay were more likely to have a pre-
liminary diagnosis of gastrointestinal/hepatic and renal
disorders, and pulmonary disorders were more common
among the patients without AKI. The elderly patients
with AKI also had significantly lower initial SBP, DBP,
and eGFR than those without AKI (Table 2).
Using the Cox proportional hazard regression analyses,
we constructed the cumulative hazard curves of AKI
over the patients’ ED stay, based on elderly patients who
presented with and without thrombocytopenia on the
first day of ED visit (Fig. 1). We also used stepwise Cox
proportional hazard regression analyses to delineate the
relationship between initial thrombocytopenia or platelet
counts on the day of ED visit and subsequent AKI after
ED stay. The proportionality of platelet counts over the
follow-up period was reassured by testing Schoenfeld re-
siduals (p = 0.064). The stepwise Cox regression analyses
revealed that lower initial platelet counts were predictive
Table 2 Comparison of elderly patients with and without AKI after emergency department stay
Characteristics AKI after ED stay No AKI after ED stay p value
Demographic features
Age (years) 79.6 ± 8.4 81.5 ± 7.9 0.19
Gender (male %) 33 (58) 35 (44) 0.12
Comorbidities
Diabetes mellitus (%) 28 (49) 25 (32) 0.04
Hypertension (%) 28 (49) 50 (63) 0.1
Heart failure (%) 12 (21) 11 (14) 0.28
Coronary artery disease (%) 4 (7) 7 (9) 0.7
Peripheral artery occlusive disease (%) 3 (5) 6 (8) 0.59
Chronic obstructive pulmonary disease (%) 7 (12) 8 (10) 0.7
Chronic kidney disease (%) 31 (54) 23 (29) < 0.01
Previous or active malignancy (%) 18 (32) 17 (22) 0.19
Peptic ulcer disease (%) 7 (12) 5 (6) 0.23
Charlson comorbidity index 8 (6–10) 7 (6–8) 0.02
Initial impression (%) < 0.01
Cardio- or cerebro-vascular events 2 (4) 9 (11)
Pulmonary diseases 23 (40) 40 (51)
Gastrointestinal and hepatic diseases 13 (23) 8 (10)
Renal diseases 11 (19) 3 (4)
Infection of unknown origin 2 (4) 9 (11)
Miscellaneous 6 (11) 10 (13)
First vital signs obtained on ED evaluation
Systolic blood pressure (mmHg) 114 (95–141) 144 (123–162) < 0.01
Diastolic blood pressure (mmHg) 64 (54–75) 78 (69–90) < 0.01
Heart rate (/min) 94.5 ± 23.3 98.3 ± 18.8 0.3
Body temperature (°C) 37 ± 1.3 37.4 ± 1.1 0.06
Respiratory rate (/min) 19 (18–21) 20 (18–22) 0.69
First laboratory data on ED
Leukocyte counts (K/μL) 12.3 (7.7–16.2) 10.6 (8–14.6) 0.12
Hemoglobin (g/dL) 9,7 (7.9–12) 11.7 (10.5–13.1) 0.06
Platelet counts (K/μL) 200 ± 100 243 ± 100 0.01
Baseline eGFR (ml/min/1.73 m2) 58.8 (33.5–83.8) 76.5 (51.1–91) < 0.01
Serum creatinine on ward admission (mg/dL) 1.9 (1.4–2.5) 0.8 (0.6–1.1) < 0.01
ED length of stay (days) 4 (3–5) 5 (3–6) 0.19
Data are expressed as mean ± standard deviation or median with 25% and 75% quartiles for continuous variables, and number (percentage) for categorical variables
Abbreviation: AKI acute kidney injury, ED emergency department, eGFR estimated glomerular filtration rate
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of a higher AKI risk (hazard ratio [HR] 0.997 per
103/μL, 95% confidence interval [CI] = 0.994–0.999),
and the presence of initial thrombocytopenia was
similarly associated with a higher risk of subsequent
AKI (HR 1.86, 95% CI = 1.06–3.27) among these
patients (Table 3). The sensitivity analyses accounting
for nephrotoxic medications use, including non-
steroidal anti-inflammatory drugs, vancomycin, and
contrast, disclosed that lower initial platelet counts were
still predictive of a higher AKI risk (HR 0.997 per 103/μL,
95% CI = 0.994–0.999), while thrombocytopenia was asso-
ciated with a higher risk of subsequent AKI (HR 1.85, 95%
CI = 1.05–3.28) (Table 3). The cumulative hazard curve
constructed based on the sensitivity analyses showed simi-
lar findings (Fig. 2).
Discussion
In the current study, we discovered that thrombocytopenia
was common among elderly patients who visited the ED
for medical illnesses; it occurred in nearly one-fourth
of these medical encounters. After the ED stay, about
40% of the elderly patients were diagnosed with AKI,
and those with subsequent AKI had more comorbidi-
ties as well as poorer renal function than the patients
without AKI. The regression analyses that accounted
for clinical features, initial diagnoses, and laboratory
data revealed that the presence of thrombocytopenia
on initial evaluation predicted nearly 2-fold higher
risk of subsequent AKI, and the initial platelet count
was a continuous variable that also exhibited a nega-
tive correlation with the subsequent risk of AKI. The
sum of these findings suggests that checking a
complete blood count can be a useful approach for
estimating the risk of later AKI among elderly
patients who present to the ED.
The prevalence of thrombocytopenia in this study fell
within the range reported by other investigators. A
decade-old study suggested that only 1% of all patients
admitted to a general acute care hospital had
thrombocytopenia [22]. However, as clinicians have in-
creasingly recognized the importance of blood rheology,
the frequency of complete blood count testing has risen,
contributing to a higher incidence of thrombocytopenia
being identified. Large scale studies have suggested that
on average 8–36% of in-patients have thrombocytopenia,
and the number increases further to 13–68% if they
received specific medications (e.g., heparin), were admit-
ted to intensive care units, or had higher illness severity
[23, 24]. Since the current study focuses on geriatric
Fig. 1 Cumulative hazard curve based on Cox proportional hazard
regression analyses for evaluating the hazard of developing AKI after
ED stay, based upon thrombocytopenia or not (solid line, without
thrombocytopenia; dashed line, with thrombocytopenia).
Abbreviation: AKI, acute kidney injury; ED, emergency department
Table 3 Regression analyses with AKI after ED stay as the
dependent variable
Cox proportional hazard regression Hazard ratio 95% CI p value
Model 1: PLT count as variable
Comorbid CKD 1.88 1.11–3.2 0.02
Comorbid CHF 1.86 0.96–3.59 0.07
SBP at ED (per mmHg) 0.984 0.975–0.994 < 0.01
Platelet count (per 103/μL) 0.997 0.994–0.999 0.02
Model 2: thrombocytopenia or not as variable
Comorbid CKD 1.96 1.15–3.32 0.01
Comorbid CHF 1.96 1.01–3.83 0.048
SBP at ED (per mmHg) 0.984 0.974–0.993 < 0.01
Thrombocytopenia 1.86 1.06–3.27 0.03
aSensitivity analyses: Model S1, PLT count as variable
Comorbid CKD 1.77 1.01–3.09 0.04
Comorbid CHF 2.51 1.23–5.14 0.01
Comorbid malignancy 1.82 0.99–3.34 0.05
DBP at ED (per mmHg) 0.971 0.954–0.988 < 0.01
Platelet count (per 103/μL) 0.997 0.994–0.999 0.01
aSensitivity analyses: Model S2, thrombocytopenia or not as variable
Comorbid CKD 1.99 1.16–3.39 0.01
Comorbid CHF 1.93 0.99–3.74 0.05
SBP at ED (per mmHg) 0.983 0.973–0.993 < 0.01
Thrombocytopenia 1.85 1.05–3.28 0.03
Model 1 and 2 included demographic features (age and gender), all
comorbidities in Table 1, vital sign parameters (blood pressure and heart
rates), and first laboratory data obtained (leukocytes, hemoglobin, and
platelet counts)
aSensitivity analysis models included demographic features (age and gender),
all comorbidities in Table 1, vital sign parameters (blood pressure and heart
rates), first laboratory data obtained (leukocytes, hemoglobin, and platelet
counts), and use of NSAID, vancomycin, and contrast
Abbreviations: AKI acute kidney injury, CI confidence interval, CKD chronic
kidney disease, CHF congestive heart failure, DBP diastolic blood pressure, ED
emergency department, NSAID non-steroidal anti-inflammatory drug, PLT
platelet, SBP systolic blood pressure
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patients with a mean age of 80.7 years, the percentage of
patients visiting the ED with thrombocytopenia (22.8%)
in this study seems reasonable. Similarly, the incidence
of AKI in our geriatric cohort approximates the rates re-
ported in the literature, since most of them suggest that
the incidence falls between 30 and 40% among patients
with extremely advanced age [1, 5, 6].
Prior studies have revealed that aberrant platelet levels,
both thrombocytosis and thrombocytopenia, can be im-
portant outcome determinants among patients with epi-
sodes of acute inflammation or infection. Mirsaeidi et al.
reported that admission platelet counts higher than 400
× 103/μL or lower than 100 × 103/μL predicted a higher
30-day mortality among patients with community-
acquired pneumonia [25]. Prina et al. similarly indicated
that the presence of thrombocytosis increased the risk of
mortality and also the incidence of respiratory complica-
tions among patients with pneumonia [26]. In the
Program to Improve Care in Acute Renal Disease
(PICARD) study, the researchers discovered that
thrombocytopenia early in the course of hospitalization
also predicted a 60 to 110% higher risk of mortality
among patients with critical illnesses [27]. However,
studies linking thrombocytopenia and renal complica-
tions have been sparse and available reports illustrating
the relationship between thrombocytopenia and AKI
have mostly focused on patients undergoing invasive
procedures. Van Linden et al. reported that the occur-
rence of thrombocytopenia in patients undergoing aortic
valve implantation was associated with an increased AKI
risk [28]. Aregger et al. also discovered a higher fre-
quency of post-procedural thrombocytopenia as a sig-
nificant risk factor for AKI after trans-aortic valve
implantation [12]. We hypothesized that similar finding
might exist for patients who did not undergo invasive in-
terventions, and we observed that thrombocytopenia
detected during the initial evaluation of patients with
medical illness alone also predicted a higher risk of
developing AKI (Table 3). These results lend support to
our conclusion that thrombocytopenia is an important
predictor of adverse outcomes, including not only higher
mortality, but also an elevated risk of AKI. Our findings
further suggest that this relationship applies similarly to
the elderly, a population that is more susceptible to
developing thrombocytopenia and AKI from clinical
insults.
The participants in this study were somewhat older
than the general population, with a high proportion hav-
ing multimorbidity. This is related to our hypothesis that
older adults are at higher risk of developing AKI, and we
specifically enrolled those with age higher than 65 years.
This advanced age might be reflective of the burden of
population aging on the healthcare practice in our
institute. In addition, increased platelet counts can be
associated with inflammatory status. However, platelet
counts are also affected by factors other than inflamma-
tion, including infection processes with platelet
consumption, bone marrow reserve, and hepatic diseases
[29]. Patients with hepatic disease (e.g. cirrhosis) or
severe infection (e.g. sepsis) tend to develop leukopenia
related to bone marrow suppression or splenic seques-
tration [30]. In Table 1, we observed a numerically
higher percentage of thrombocytopenic patients
presenting with gastrointestinal/hepatic diseases and
infection of unknown origin than those without
thrombocytopenia, although the difference did not reach
statistical significance (p = 0.23). Consequently, we
propose that thrombocytopenic patients in this study
might exhibit a mixture of inflammation but a relatively
higher prevalence of hepatic disease and/or infection
than those without thrombocytopenia, leading to
leukopenia (Table 1). The advanced age of these patients
might partially underlie the exaggerated differences in
leukocyte counts between thrombocytopenic patients
and non-thrombocytopenic ones.
The rationale behind the relationship between initial
thrombocytopenia and subsequent AKI is complex.
Platelet count has been purported to be a marker for
disease severity during acute illnesses of different nature,
such as Plasmodium infection and Dengue fever [31,
32]. As inflammation/infection worsens, the consump-
tion of platelet and thrombocytopenia may increase, and
it may be compounded by local sequestration, dissemi-
nated intravascular coagulation and endothelial activa-
tion, leading to a further decline in platelet numbers
[25]. An earlier presentation of thrombocytopenia during
the disease course thus can be an occult indicator for
ongoing inflammation, and persistent inflammation is a
Fig. 2 Cumulative hazard curve based on Cox proportional hazard
regression analyses results of the sensitivity analyses (solid line,
without thrombocytopenia; dashed line, with thrombocytopenia).
Abbreviation: AKI, acute kidney injury; ED, emergency department
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potential risk factor for AKI susceptibility [33]. In
addition to their pro-coagulation and hemostatic effects,
circulating platelets also exhibit immune-regulatory and
anti-microbial ability by releasing peptides active against
pathogens as well as through microorganism internaliza-
tion [34]. Furthermore, an anecdotal report suggested
that thrombocytopenia might directly contribute to the
propagation of infection by lowering the secretion of
transforming growth factor-β1 and altering cytokine rep-
ertoire [35]. Clinically, thrombocytopenia also confers a
state of bleeding diathesis and increases the risk of
major hemorrhage. There have been reports that
thrombocytopenia elevated the risk of major bleeding
complications by 4-fold among patients with acute myo-
cardial infarction [36]. Severe bleeding with resultant
hemodynamic instability is also a common predisposing
event before hospital-acquired AKI. Finally, resuscitation
for shock or massive fluid administration might cause
dilutional thrombocytopenia, and such a clinical scenario
is frequently accompanied by AKI [10, 37]. In our co-
hort, the predominant cause of AKI was ATN. In
addition, we found that elderly patients who presented
with thrombocytopenia had significantly lower leukocyte
counts than the patients without thrombocytopenia
(p < 0.01; Table 1), suggesting that a dilutional origin
was another possible explanation. Although we did
not measure inflammatory markers or assess fluid sta-
tus among all the participants, we propose that
thrombocytopenia might be an early marker for per-
sistent inflammation or an excess volume status, lead-
ing to susceptibility for AKI, or it might even play a
directly pathogenic role in immune-dysregulation,
precipitating severe infections and resultant AKI.
Based on our findings, it may be worthwhile to order
an assay for platelet count among elderly patients
presenting to ED for medical illnesses, for gauging
their AKI risk. Avoidance of nephrotoxin exposure
could also be considered for elderly patient who
present to the ED with thrombocytopenia.
Our study has its strengths but is also limited in sev-
eral aspects. The existence of a relationship between ini-
tial thrombocytopenia and the subsequent risk of AKI
has only been reported among patients undergoing inva-
sive procedures in the existing literature, and we con-
firmed the same connection in elderly patients with
medical illnesses. However, the relatively modest number
of cases, the absence of data about inflammatory
markers, the single center study design, and the restric-
tion of patients to those admitted to general medical
wards only, reduce the generalizability of our findings. A
competing risk from death during ED stay should also
be considered when interpreting our results, although
the mortality rate in our ED is relatively low. The lack of
data on inflammatory markers and the absence of a fluid
status assessment limit the interpretation of the relationship
between thrombocytopenia and AKI observed in this study.
In addition, depending upon clinical settings, the etiologies
of AKI differ, and sepsis has been reported to be the leading
cause of AKI [38]. In the current study, the possibility exists
that the presence of sepsis partially accounts for the associ-
ation between thrombocytopenia and the occurrence of
AKI, although we have tried to adjust for this issue by con-
sidering relevant parameters including leukocyte counts
and physiologic variables such as blood pressure and heart
rate in the regression models. Furthermore, the extensive
adjustment of known interfering variables and the existence
of a dose-dependent relationship (higher AKI severity,
greater decline in platelet count) strengthens the credibility
of our results. Finally, results from our current approach
might be influenced by the possibility that some partici-
pants would develop AKI but went unnoticed before they
were admitted. A fixed time period model would be more
appropriate in this regard. More studies are needed for
validation.
Conclusion
AKI constitutes an important concern for hospitalized
patients, particularly those of advanced age, since the de-
velopment of AKI increases their risk of adverse out-
comes. Few studies have addressed the risk factors for
AKI among geriatric patients, and none of the existing
studies used thrombocytopenia or platelet counts as a
predictive variable, despite its simplicity and wide avail-
ability. By prospectively recruiting elderly patients with
medical illnesses who visited the ED, we discovered that
thrombocytopenia detected during the initial evaluation
significantly increased the risk of subsequent AKI, and
the risk of AKI rose progressively with lower initial
platelet counts. Checking the platelet level could be an
informative approach for evaluating renal outcomes
among elderly patients; it might be rational to avoid
nephrotoxin exposure, optimize hemodynamic status,
and provide early treatment of underlying diseases
among thrombocytopenic elderly patients in the ED.
Abbreviation
AKI: Acute kidney injury; CCI: Charlson comorbidity index; CHS: Cardiovascular
Health Study; CI: Confidence Interval; CKD: Chronic kidney disease; CKD-
EPI: Chronic Kidney Disease Epidemiology Collaboration; DBP: Diastolic blood
pressure; DM: Diabetes mellitus; ED: Emergency department; eGFR: Estimated
glomerular filtration rate; HR: Hazard ratio; KDIGO: Kidney Disease Improving
Global Outcomes; NTUH: National Taiwan University Hospital; PICARD: Program
to Improve Care in Acute Renal Disease; SBP: Systolic blood pressure; Scr: Serum
creatinine
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